MedTrace Logo

A RETROspective Study of Patients With TK2d

NCT03701568 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38

Last updated 2023-09-01

No results posted yet for this study

Summary

This is a medical chart review study to collect information for patients who have been taking pyrimidine nucleosides for treatment of TK2 deficiency. Information from the time of onset of symptoms will be collected to describe the pre treatment course of TK2 deficiency.

Conditions

  • Thymidine Kinase 2 (TK2)

Interventions

DRUG

dC/dT

Collection of retrospective data from TK2 patients previously treated with dC/dT

Sponsors & Collaborators

  • Zogenix MDS, Inc.

    lead INDUSTRY

Principal Investigators

  • UCB Cares · 001 844 599 2273

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-19
Primary Completion
2019-04-30
Completion
2019-05-31

Countries

  • United States
  • Israel
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03701568 on ClinicalTrials.gov